Fundraising FoxCamp4 Therapeutics Corp
NASDAQ: CAMPCambridge, US · Founded 2015 · Delaware corporation · 4 known investors
Find your way into Camp4 Therapeutics Corp
Sign up to see every warm intro you have to Camp4 Therapeutics Corp
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Camp4 Therapeutics Corp team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Camp4 Therapeutics develops antisense oligonucleotides targeting regulatory RNAs to increase gene expression and restore healthy protein levels for genetic diseases, with an initial focus on treating SYNGAP1-related developmental and epileptic encephalopathy.
Founders & leadership
Camp4 Therapeutics Corp was founded in 2015 by Richard Young.
Board
Investors · 4
How we know: 5AM Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$179.6M disclosed across 3 rounds · 2018–2022
▶$100.5MraisedJun 2022 · 16 investors · BiotechnologyRule 506(b)
- PAULA RAGANDirector
- STEVE HOLTZMANDirector
- MICHAEL HIGGINSDirector
- RAVI I. THADHANIDirector
- RICHARD YOUNGDirector
- AMIR NASHATDirector
- CALEB MOOREExecutive Officer
- JORGE CONDEDirector
- SHAAN GANDHIDirector
- JOSH MANDEL-BREHMExecutive Officer, Director
- ANN BARBIERExecutive Officer
- ALFICA SEHGALExecutive Officer
- MICHELLE GATESExecutive Officer
- KELLY GOLDExecutive Officer
- DAVID BUMCROTExecutive Officer
- ANDREW J. SCHWABDirector
- JAMES BOYLANDirector
- Amount sold
- $100.5M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedOct 2021 · 7 investors · BiotechnologyRule 506(b)
- JORGE CONDEDirector
- RAVI THADHANIDirector
- ALFICA SEHGALExecutive Officer
- SHAAN GANDHIDirector
- PAULA RAGANDirector
- MICHELLE GATESExecutive Officer
- STEVE HOLTZMANDirector
- CALEB MOOREExecutive Officer
- MICHAEL HIGGINSDirector
- AMIR NASHATDirector
- KELLY GOLDExecutive Officer
- RICHARD YOUNGDirector
- JOSH MANDEL-BREHMExecutive Officer, Director
- ANDY SCHWABDirector
- DAVID BUMCROTExecutive Officer
- Amount sold
- $45M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.1MraisedSep 2018 · 6 investors · BiotechnologyRule 506(b)
- RICHARD YOUNGDirector
- MICHAEL HIGGINSDirector
- JORGE CONDEDirector
- JOSH MANDEL-BREHMExecutive Officer, Director
- AMIR NASHATDirector
- Offering amount
- $34.1M
- Amount sold
- $34.1M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Camp4 Therapeutics Corp do?
- Camp4 Therapeutics develops antisense oligonucleotides targeting regulatory RNAs to increase gene expression and restore healthy protein levels for genetic diseases, with an initial focus on treating SYNGAP1-related developmental and epileptic encephalopathy.
- Who founded Camp4 Therapeutics Corp?
- Camp4 Therapeutics Corp was founded by Richard Young in 2015.
- Who are Camp4 Therapeutics Corp's investors?
- Camp4 Therapeutics Corp's investors include 5AM Ventures, Andreessen Horowitz, Longwood Fund, Polaris Partners.
- How much funding has Camp4 Therapeutics Corp raised?
- Camp4 Therapeutics Corp has disclosed $179.6M raised across 3 rounds.
- Where is Camp4 Therapeutics Corp headquartered?
- Camp4 Therapeutics Corp is headquartered in Cambridge, US.